Arina A. Chepanova
- Molecular Biology
- Organic Chemistry top 10%
- Pharmacology top 10%
- Toxicology top 2%
- Oncology
- Co-authors
- Olga I. LavrikНариман Ф. СалахутдиновAlexandra L. ZakharenkoJóhannes ReynissonКонстантин П. ВолчоOlga D. ZakharovaOlga A. LuzinaNadezhda S. Dyrkheeva
- Topics
- Cancer therapeutics and mechanisms (23 papers)Synthesis and bioactivity of alkaloids (6 papers)Bioactive Compounds and Antitumor Agents (5 papers)
- Journals
- International Journal of Molecular SciencesMoleculesEuropean Journal of Medicinal Chemistry
- Partner nations
- RussiaUnited KingdomNew Zealand
In The Last Decade
Arina A. Chepanova
23 papers receiving 442 citations
Peers
Comparison fields: 5 of 48
- Molecular Biology 344
- Organic Chemistry 161
- Pharmacology 112
- Toxicology 95
- Oncology 93
Countries citing papers authored by Arina A. Chepanova
This map shows the geographic impact of Arina A. Chepanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arina A. Chepanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arina A. Chepanova more than expected).
Fields of papers citing papers by Arina A. Chepanova
This network shows the impact of papers produced by Arina A. Chepanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arina A. Chepanova. The network helps show where Arina A. Chepanova may publish in the future.
Co-authorship network of co-authors of Arina A. Chepanova
This figure shows the co-authorship network connecting the top 25 collaborators of Arina A. Chepanova. A scholar is included among the top collaborators of Arina A. Chepanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arina A. Chepanova. Arina A. Chepanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2 | |
| 3 | 18 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 10 | |
| 9 | 16 | |
| 10 | 25 | |
| 11 | 28 | |
| 12 | 19 | |
| 13 | 29 | |
| 14 | 39 | |
| 15 | 36 | |
| 16 | 10 | |
| 17 | 19 | |
| 18 | 64 | |
| 19 | 32 | |
| 20 | 18 |
About Arina A. Chepanova
Arina A. Chepanova is a scholar working on Toxicology, Molecular Medicine and Molecular Biology, having authored 23 papers that have together received 443 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (23 papers), Synthesis and bioactivity of alkaloids (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Toxicology (95 citations), Pharmacology (112 citations) and Organic Chemistry (161 citations). Arina A. Chepanova has collaborated with scholars based in Russia, United Kingdom and New Zealand. Frequent co-authors include Olga I. Lavrik, Нариман Ф. Салахутдинов, Alexandra L. Zakharenko, Jóhannes Reynisson, Константин П. Волчо, Olga D. Zakharova, Olga A. Luzina, Nadezhda S. Dyrkheeva, Ekaterina S. Ilina and Ivanhoe K. H. Leung. Their work appears in journals such as International Journal of Molecular Sciences, Molecules and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.